Results provide a mechanistic explanation of why early loss of p53 signaling is frequently observed in UC-associated ...

A team of researchers led by Kimberly Hartl, a graduate student at the Berlin Institute for Medical Systems Biology of the ...

Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité – Universitätsmedizin Berlin have elucidated ...

Researchers have elucidated the role of the p53 gene in ulcerative colitis. The study suggests a potential new drug target to stop disease progression to cancer.

New research highlights a pivotal role for the p53 gene in ulcerative colitis progression, offering a potential therapeutic ...

The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on.

In a recent perspective published in the journal Cell Death and Differentiation, researchers in France, Germany, and Sweden ...

It seems, the team found, that some species may be more at risk of developing cancer than others. Among those with unusually ...